SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH M impact

FDA Approves Lucamzi, Xbrane Biopharma Says

The headline reports FDA approval of Lucamzi, a product of Xbrane Biopharma.

Related stories